Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

NCT04431778 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Neuropathic Pain

Interventions

DRUG: Ethosuximide
DRUG: Placebo

Sponsor

University Hospital, Clermont-Ferrand